Recently Featured

Congress Must Prioritize Strategic Health Diplomacy to Enhance Global and Domestic Well-Being

June 20, 2026
The recent hantavirus outbreak and the ongoing Ebola crisis underscore the urgent need for Congress to prioritize global health as a key component of U.S. foreign policy. The interconnectedness of health challenges highlights that the well-being of Americans is inextricably linked to the health of populations worldwide. As such, strategic health diplomacy should be at…

Kardigan extends biotech’s streak of big IPOs with $400M haul

June 20, 2026
Kardigan has successfully raised $400 million in its initial public offering (IPO), marking a significant milestone in the biotech sector. This achievement brings the total number of biotech firms that have raised at least $400 million in IPO proceeds to four in 2026, the highest tally in a single year since 2021, according to data…

$700 Million in Mental Health Funding Announced, Experts Question Novelty

June 20, 2026
The Trump administration has announced a $700 million initiative aimed at enhancing mental health and addiction programs, particularly those addressing homelessness linked to severe mental illness. This funding has been touted as a significant step forward in tackling a pressing public health issue. However, behavioral health experts have raised concerns regarding the characterization of this…

FDA Approves First Single-Dose Generic Treatment for Influenza

June 20, 2026
The U.S. Food and Drug Administration today approved the first generic version of Xofluza (baloxavir marboxil) tablets, marking a significant milestone in the treatment of acute uncomplicated influenza. This generic formulation is designed for patients aged 5 years and older, providing a single-dose option that simplifies treatment protocols. This approval not only enhances the therapeutic…

Ongoing Cases